25 October 2019 : Clinical Research
Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry StudyYan-Ming Li12AEF, Chao Jiang1DEF, Liu He1C, Xin-Xu Li3C, Xiao-Xia Hou2B, San-Shuai Chang1BE, Gregory Y.H. Lip4ADE, Xin Du15ACDE*, Jian-Zeng Dong16ADEG, Chang-Sheng Ma1AG
Med Sci Monit 2019; 25:8011-8018
BACKGROUND: There is a growing recognition of sex-related disparities in atrial fibrillation (AF). However, limited data is available in Chinese AF patients.
MATERIAL AND METHODS: We compared symptoms, quality of life (QoL), and treatment of AF according to sex from the China AF Registry study.
RESULTS: We studied 14 723 patients with non-valvular AF, of whom 5645 patients (38.3%) were female. Women were older than men (67.5±10.6 vs. 62.2±12.2). Compared to men, women had more comorbidities and a higher proportion of CHA₂DS₂-VASC score ≥2. Women with AF experienced more severe or disabling symptoms than men (33.7% vs. 22.9% in age <75 group; 40.3% vs. 28.7% in age ≥75 group; both P<0.0001). After multivariate analysis, women with AF still had lower QoL (OR 0.69; 95%CI, 0.63–0.76; P<0.0001). Women tended to have lower rates of ablation and rhythm-control drug use in those aged <75 years. Oral anticoagulant use was low and had no sex difference in AF patients with a CHA₂DS₂-VASC score ≥2.
CONCLUSIONS: In Chinese AF patients, women were older and more symptomatic, and had worse QoL. Despite all these differences, women tended to receive less rhythm-control treatment in those aged <75 years. Oral anticoagulant was substantially underused in high stroke risk patients, regardless of sex.
Keywords: Atrial Fibrillation, Quality of Life, Sex Characteristics, Therapeutics, Aged, Aged, 80 and over, Anticoagulants, Comorbidity, Middle Aged, Registries, Risk Assessment, Risk Factors, Sex Factors, Stroke, Treatment Outcome
01 September 2023 : EditorialEditorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2
Med Sci Monit 2023; 29:e942244
22 Sep 2023 : Clinical ResearchComparative Analysis of Symptomatology in Hospitalized Children with RSV, COVID-19, and Influenza Infections
Med Sci Monit In Press; DOI: 10.12659/MSM.941229
21 Sep 2023 : Clinical ResearchThe Impact of Implementing the Vortex Approach on Airway Management Performance in Stressed Medical Student...
Med Sci Monit In Press; DOI: 10.12659/MSM.940372
20 Sep 2023 : Clinical ResearchChanges in Upper Airway Anatomy Following Orthodontic Treatment for Malocclusion: A Comparative Retrospecti...
Med Sci Monit In Press; DOI: 10.12659/MSM.941749
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292